| 1. | Merck Frosst Canada - Phases of Clinical Research |
| | The successful culmination of a Phase III program is a dossier of research that allows Merck & Co, Inc to seek approval to market a drug from any regulatory agency in the world.... |
| |
| 2. | Merck Frosst Canada - Records Management |
| | The library staff microfilms or scans all pertinent information regularly, to preserve important content in case of accidental damage.This scientific record-keeping is needed for legal reasons, such as the defense of patents, as well as to meet the requirements of regulatory agencies such as Health Canada.. |
| |
| 3. | Merck Frosst Canada - Clinical Research |
| | The data collected becomes part of Merck Frosst submissions to regulatory agencies around the world and are necessary to obtain licenses to market new drugs.... |
| |
| 4. | Merck Frosst Canada - Executive Speeches |
| | Results of these clinical studies are used by regulatory agencies such as the FDA or Health Canada to grant authorization to bring a product to market.... |
| |
| 5. | Merck Frosst Canada - Section Reserved For Media |
| | The fact that an adverse event has been reported to Merck and to regulatory agencies does not reflect a conclusion that the post-marketing event is caused by SINGULAIR.... Merck has been working with regulatory agencies worldwide to update the prescribing information in those countries.... |
| |
